{"id":1669,"date":"2022-12-05T08:37:02","date_gmt":"2022-12-05T14:37:02","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=1669"},"modified":"2022-12-13T11:21:07","modified_gmt":"2022-12-13T17:21:07","slug":"11-of-covid-19-survivors-have-residual-lung-damage-study-finds","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2022\/12\/05\/11-of-covid-19-survivors-have-residual-lung-damage-study-finds\/","title":{"rendered":"11% of COVID-19 survivors have residual lung damage, study finds"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p>(<a href=\"https:\/\/www.cidrap.umn.edu\/news-perspective\/2022\/12\/11-covid-19-survivors-have-residual-lung-damage-study-finds\">CIDRAP<\/a>) A new study\u00a0in the\u00a0<em>American Journal of Respiratory and Critical Care Medicine<\/em>\u00a0reveals about an 11% incidence of residual lung damage\u2014known as interstitial lung disease\u2014after COVID-19 hospitalization. Interstitial lung disease is a broad category of lung damage and disease defined by fibrotic scarring. The damage is often irreversible. <a href=\"https:\/\/www.thoracic.org\/about\/newsroom\/press-releases\/resources\/lung_abnormalities_after_covid19.pdf\">Link to Study<\/a><\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>(CIDRAP) A new study\u00a0in the\u00a0American Journal of Respiratory and Critical Care Medicine\u00a0reveals about an 11% incidence of residual lung damage\u2014known as interstitial lung disease\u2014after COVID-19 hospitalization. Interstitial lung disease is a broad category of lung damage and disease defined by fibrotic scarring. The damage is often irreversible. Link to Study<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[13,11],"tags":[],"class_list":["post-1669","post","type-post","status-publish","format-standard","hentry","category-clinical-considerations","category-covid"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=1669"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1669\/revisions"}],"predecessor-version":[{"id":1670,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/1669\/revisions\/1670"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=1669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=1669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=1669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}